Dermatologic Therapy Journal Citation Rate 2026
1396-0296
eISSN 1529-8019
Wiley
US
Q3 Quartile Verified Publisher
About Dermatologic Therapy
Dermatologic Therapy (DT) is a peer-reviewed academic journal covering Autoimmune Bullous Skin Diseases and Dermatologic Treatments and Research, published by Wiley in US, catalogued under ISSN 1396-0296 (e-ISSN 1529-8019). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 0.67 (Q3 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$2500 USD).
Dermatologic Therapy Citation Rate 2026 — In Context
Dermatologic Therapy has a 2025 2-Year Citation Rate (OpenAlex) of 0.67, placing it in the Q3 quartile within the Autoimmune Bullous Skin Diseases research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
Dermatologic Therapy operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.
Researchers looking to publish in Dermatologic Therapy should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Dermatologic Therapy against similar journals in the field, use our journal comparison tool.
Submission Tips for Dermatologic Therapy
- Budget $2500 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers Autoimmune Bullous Skin Diseases, Dermatologic Treatments and Research, Dermatology and Skin Diseases. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Dermatologic Therapy Compares
Compared against 11 journals in the same research areas.
| ISSN (Print) | 1396-0296 |
|---|---|
| ISSN (Online) | 1529-8019 |
| Publisher | Wiley |
| Country | United States |
| APC / Cost | $2500 USD |
In-depth profile & metrics
Dermatologic Therapy is published by Wiley and based in United States. It runs on a subscription or hybrid model with an article-processing charge of USD 2500.
In our subject taxonomy, Dermatologic Therapy is classified under Autoimmune Bullous Skin Diseases, Dermatologic Treatments and Research, Dermatology and Skin Diseases and Nail Diseases and Treatments.
Dermatologic Therapy is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 0.668.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Dermatologic Therapy
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 0.668 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Compare Journals
Compare Dermatologic Therapy against similar publications in its field:
Related Journals in Your Field
-
Experimental Dermatology Wiley IF 2.96
-
Journal of Cosmetic Dermatology Wiley IF 2.47
-
Clinics in Dermatology Elsevier BV IF 2.46
-
Pediatric Allergy and Immunology Wiley IF 2.21
-
Anais Brasileiros de Dermatologia Elsevier BV IF 1.43
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S67424211
Get weekly updates for Autoimmune Bullous Skin Diseases journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.